Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a monoclonal antibody therapy for patients with brain tumors and melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cancer
• Melanoma

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors, Melanoma (Skin) | Phase 1 | Status: COMPLETED